Chiefy is a hospital and health care company that specializes in zero waste and zero harm in surgery. Chiefy makes it easy for surgeons, anesthesiologists, nurses, and other stakeholders to align on the case plan earlier through asynchronous virtual huddles. It captures lessons, notes, and feedback after procedures and drives continuous improvement. With Chiefy, quality and communication best practices are seamlessly baked into daily operations, helping teams collaborate strikingly smarter and get closer to patients. Founded by Maya Ber Lerner and Assaf Ziv in 2020, it is located in New York, New York.
Formulator operates a mental healthcare platform designed to assist individuals in articulating their circumstances and objectives, which can then be shared with their therapists. The platform features a structured case formulation tool that enables users to identify and address underlying issues from the outset of their treatment. By facilitating clearer communication between patients and healthcare providers, Formulator enhances the efficiency and effectiveness of mental health care, ultimately aiming to improve patient outcomes and optimize the therapeutic process.
Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database.
Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.
MedaSystems operates a cloud-based platform that facilitates collaboration between life science companies and healthcare providers regarding access to experimental therapies. The platform streamlines the management of requests for investigational medicines by incorporating configurable workflows and a form builder that captures complex, structured data specific to therapies. It also features task management and tracking capabilities, as well as integration with machine learning libraries. This comprehensive approach enables manufacturers to effectively work with physicians on various request types, including expanded access, named patient programs, investigator-sponsored trial requests, and post-trial access.
Quantivly, Inc. develops artificial intelligence based solutions for radiology. The company was incorporated in 2019 and is based in Somerville, Massachusetts.
Neucruit is a government-backed venture that utilizes deep tech to build digital patient recruitment strategies to improve the lives of patients and clinical innovators. The London, England-based company was founded in 2019.
Zetta Genomics manages large-scale genomic data for precision medicine. The company employs distributed database technology and best practice security techniques to leverage genomic data benefits while preserving data privacy. Zetta Genomics was founded in 2018 and is based in Cambridge, England.
hi.health offers people with private health insurance convenient and safe access to health care billing via app or web. Users can easily submit their invoices digitally and hi.health takes care of the further processing, billing and customer service providing a seamless user experience. With the integrated “library” users receive a transparent overview of relevant digital health products and services, that are (partially) covered by their insurance. hi.health operates at the intersection of digital health, fintech and insurtech. While each of these rapidly growing markets are already exciting in themselves, their combination in one product is unique. The company was founded by Sebastian Gruber and Fredrik Debong in July 2019. Since hi.health launched in Germany at the end of 2019 several thousand users already use the independent billing app.
We are a technology company which provides a platform called “Medall”. Medall is a web application to enable healthcare professionals and students to connect in a professional network, to store, organise and display their professional achievements and to facilitate collaboration between, and professional matching of, users of the application based on their development needs and existing skills. Medall also enables healthcare organisations (“Organisational Users”) to promote their organisational aims, to communicate with members, to offer training, content, poster halls, certificates and events to members and to participate in discussions and development involving matters of healthcare.
We are a technology company which provides a platform called “Medall”. Medall is a web application to enable healthcare professionals and students to connect in a professional network, to store, organise and display their professional achievements and to facilitate collaboration between, and professional matching of, users of the application based on their development needs and existing skills. Medall also enables healthcare organisations (“Organisational Users”) to promote their organisational aims, to communicate with members, to offer training, content, poster halls, certificates and events to members and to participate in discussions and development involving matters of healthcare.
Cardiomatics uses artificial intelligence tools for Cardiology. Their service uses global HIPAA compliant services that guarantee safety, and accessibility from anywhere in the world. The effectiveness of their algorithms has been verified on the benchmark database developed by Boston's Beth Israel Hospital and MIT. Cardiomatics was founded in 2017 and is based in Poland.
Lena develops a social event information application software designed for senior citizens. The company specializes in developing an app that introduces seniors to events they love in their own communities. It enables users to connect to social circles, and encourage them to participate in activities through gamified rewards.
Cardiomatics uses artificial intelligence tools for Cardiology. Their service uses global HIPAA compliant services that guarantee safety, and accessibility from anywhere in the world. The effectiveness of their algorithms has been verified on the benchmark database developed by Boston's Beth Israel Hospital and MIT. Cardiomatics was founded in 2017 and is based in Poland.
EarlySight SA, founded in 2016 and based in Lausanne, Switzerland, develops medical devices aimed at early detection and treatment of eye diseases. The company specializes in an advanced eye fundus camera that captures detailed images of the retina by combining eye illumination with real-time correction of ocular aberrations. EarlySight focuses on accelerating the development of its technology to facilitate its adoption in clinical settings, ultimately enhancing diagnostic precision and patient care in ophthalmology.
moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO 13485 certification.
contextflow GmbH develops and provides machine learning and artificial intelligence (AI) based solutions for radiology image search and analysis. It offers 3D image-based information search solution, which delivers summary of clinical findings, similar reference cases, and associated differential diagnosis for supporting decisions. The company has strategic partnerships with Radiology Center, Boehringer Ingelheim, and Austrian Lung Fibrosis Association. contextflow GmbH was founded in 2016 and is headquartered in Vienna, Austria.
Replica Analytics Ltd. is a company based in Ottawa, Canada, that specializes in developing modeling software for creating synthetic data derived from real clinical datasets. Established in 2019, the company focuses on generating privacy-protective synthetic data that retains the statistical characteristics of actual data. Its software technologies also include privacy assurance features to ensure the security and confidentiality of the generated datasets. By leveraging these innovative solutions, Replica Analytics addresses the growing need for data privacy in clinical research and analytics.
BioLib Technologies ApS operates platform for biological data. It delivers end-to-end bioinformatic data analytics including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure and scientific support that speeds the path from raw experimental data to new treatments and diagnostics, enabling companies to accelerate scientific discovery with fast, secure and collaborative genomic and healthcare data analytics. The company was founded in 2019 and is based in Copenhagen, Denmark.
Segmed, Inc. is a cloud-based platform that specializes in providing curated and anonymized radiology data for medical companies, primarily focused on supporting the development of artificial intelligence in healthcare. Founded in 2019 and headquartered in Menlo Park, California, Segmed's platform offers customized datasets tailored to the specific needs of its clients. The company aims to ensure that the data utilized for developing medical AI is diverse and representative, thereby reducing biases in healthcare applications. By building a robust infrastructure for accessing de-identified, structured medical imaging data, Segmed facilitates the creation of early disease detection and prediction models, ultimately contributing to the improvement of global healthcare outcomes.
PlenOptika, Inc. manufactures handheld device that provides eyeglass prescriptions. It offers QuickSee that provides accurate refractive measurements for eyes. The device facilitates optometry in rural and low-resource settings. The company was formerly known as Team Eye. PlenOptika, Inc. was incorporated in 2014 and is based in Allston, Massachusetts.
Subtle Medical, Inc., a healthcare technology company, develops medical imaging software for clinical imaging centers and hospitals. Its product includes SubtleMR, an artificial intelligence-based image processing software that reduces image noise and increases image sharpness for non-contrast enhanced magnetic resonance imaging (MRI). It enables to reduce cost, imaging time, and radiation/contrast dose. The company was founded in 2017 and is based in Menlo Park, California.
Sarcura GmbH, founded in 2019 and located in Hinterstoder, Austria, specializes in developing a machine platform for the large-scale industrial manufacturing of personalized cell therapies aimed at treating cancer. The company utilizes semiconductor technology combined with microfluidic processing to achieve real-time control and manipulation at the cellular level. This innovative approach transforms traditional manufacturing paradigms, allowing for the production of cost-effective and safe cell therapies tailored to individual patient needs. Through its technology, Sarcura aims to enhance the accessibility and efficacy of patient-specific cancer treatments.
EarlySight SA, founded in 2016 and based in Lausanne, Switzerland, develops medical devices aimed at early detection and treatment of eye diseases. The company specializes in an advanced eye fundus camera that captures detailed images of the retina by combining eye illumination with real-time correction of ocular aberrations. EarlySight focuses on accelerating the development of its technology to facilitate its adoption in clinical settings, ultimately enhancing diagnostic precision and patient care in ophthalmology.
Methinks Software Sl, founded in 2016 and based in Barcelona, Spain, specializes in developing artificial intelligence medical software aimed at improving stroke diagnosis and treatment services. The company leverages advanced techniques in artificial intelligence, particularly utilizing Google's deep learning framework, TensorFlow, to analyze neuroimaging data for brain-related diseases. By concentrating on specific pathologies such as acute stroke, Methinks strives to achieve clinical excellence in its offerings.
Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
contextflow GmbH develops and provides machine learning and artificial intelligence (AI) based solutions for radiology image search and analysis. It offers 3D image-based information search solution, which delivers summary of clinical findings, similar reference cases, and associated differential diagnosis for supporting decisions. The company has strategic partnerships with Radiology Center, Boehringer Ingelheim, and Austrian Lung Fibrosis Association. contextflow GmbH was founded in 2016 and is headquartered in Vienna, Austria.
They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence.
To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Segmed, Inc. is a cloud-based platform that specializes in providing curated and anonymized radiology data for medical companies, primarily focused on supporting the development of artificial intelligence in healthcare. Founded in 2019 and headquartered in Menlo Park, California, Segmed's platform offers customized datasets tailored to the specific needs of its clients. The company aims to ensure that the data utilized for developing medical AI is diverse and representative, thereby reducing biases in healthcare applications. By building a robust infrastructure for accessing de-identified, structured medical imaging data, Segmed facilitates the creation of early disease detection and prediction models, ultimately contributing to the improvement of global healthcare outcomes.
Neurescue ApS, based in Copenhagen, Denmark, specializes in the development of medical devices aimed at treating cardiac arrest and hemorrhage. Founded in 2014, the company focuses on creating innovative cardiovascular solutions for emergency patients. Its flagship product, the safeREBOA device, is notable for being the first computer-aided aortic occlusion catheter, designed to enhance resuscitation rates and extend treatment time for critical patients. Neurescue is committed to advancing clinical practices through intelligent medical devices that aim to improve patient outcomes in emergency situations.
Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database.
Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.
PlenOptika, Inc. manufactures handheld device that provides eyeglass prescriptions. It offers QuickSee that provides accurate refractive measurements for eyes. The device facilitates optometry in rural and low-resource settings. The company was formerly known as Team Eye. PlenOptika, Inc. was incorporated in 2014 and is based in Allston, Massachusetts.
TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes. Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families. TeiaCare, based in Milan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
contextflow GmbH develops and provides machine learning and artificial intelligence (AI) based solutions for radiology image search and analysis. It offers 3D image-based information search solution, which delivers summary of clinical findings, similar reference cases, and associated differential diagnosis for supporting decisions. The company has strategic partnerships with Radiology Center, Boehringer Ingelheim, and Austrian Lung Fibrosis Association. contextflow GmbH was founded in 2016 and is headquartered in Vienna, Austria.
MindPeak GmbH is a Hamburg-based company founded in 2018 that specializes in developing software tools for visual diagnosis using artificial intelligence and deep learning. Its primary focus is on assisting pathologists in achieving reproducible cancer diagnostics. One of its key products, BreastAI, quantifies breast cancer immunohistochemistry (IHC) and can be integrated as a service within third-party software applications. MindPeak also optimizes workflows in pathological analysis, demonstrating its commitment to enhancing efficiency in the field. The company maintains a strategic partnership with Gestalt Diagnostics, further expanding its collaborative efforts in advancing diagnostic technologies.
Kheiron Medical Technologies Limited develops Mia, a mammography intelligent assessment tool that helps radiologists to detect breast cancer. Kheiron Medical Technologies Limited was formerly known as Maesterai Limited and changed its name to Kheiron Medical Technologies Limited in June 2016. The company was incorporated in 2016 and is based in London, United Kingdom with an additional location in San Francisco, California.
Leuko Labs develops non-invasive white blood cell monitoring device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Though its white blood cell monitoring device PointCheck, immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes.